X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2443) 2443
Publication (247) 247
Book Review (35) 35
Newsletter (25) 25
Book Chapter (14) 14
Book / eBook (9) 9
Reference (4) 4
Newspaper Article (3) 3
Conference Proceeding (2) 2
Data Set (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1628) 1628
index medicus (1201) 1201
male (1029) 1029
animals (944) 944
purines (776) 776
pharmacology & pharmacy (668) 668
sildenafil citrate (615) 615
female (520) 520
purines - pharmacology (425) 425
middle aged (397) 397
adult (389) 389
rats (352) 352
sildenafil (349) 349
pharmacokinetics (329) 329
mice (323) 323
purines - pharmacokinetics (317) 317
purines - therapeutic use (282) 282
analysis (276) 276
sulfones (266) 266
piperazines - therapeutic use (259) 259
dose-response relationship, drug (255) 255
purines - administration & dosage (249) 249
aged (243) 243
oncology (231) 231
treatment outcome (219) 219
piperazines - pharmacology (216) 216
erectile dysfunction (208) 208
chemistry, medicinal (201) 201
biochemistry & molecular biology (199) 199
cancer (195) 195
erectile dysfunction - drug therapy (194) 194
care and treatment (191) 191
piperazines - pharmacokinetics (188) 188
metabolism (185) 185
administration, oral (183) 183
purines - adverse effects (182) 182
research (182) 182
drug interactions (174) 174
piperazines - administration & dosage (172) 172
medicine & public health (170) 170
purines - chemistry (170) 170
drug therapy (151) 151
health aspects (149) 149
physiological aspects (148) 148
piperazines - adverse effects (146) 146
double-blind (142) 142
toxicology (142) 142
in-vitro (140) 140
therapy (140) 140
phosphodiesterase inhibitors - therapeutic use (137) 137
structure-activity relationship (132) 132
safety (131) 131
purines - metabolism (130) 130
adenosine (129) 129
time factors (129) 129
antineoplastic agents - pharmacology (127) 127
pharmacology/toxicology (126) 126
sulfones - therapeutic use (124) 124
purine (123) 123
rats, sprague-dawley (123) 123
pharmacology (122) 122
drugs (121) 121
urology & nephrology (121) 121
article (118) 118
metabolites (117) 117
efficacy (114) 114
cell line, tumor (113) 113
linagliptin (113) 113
phosphodiesterase inhibitors - pharmacology (112) 112
sulfones - pharmacology (112) 112
enzymes (110) 110
drug therapy, combination (109) 109
tadalafil (109) 109
neurosciences (108) 108
enzyme inhibitors - pharmacology (106) 106
expression (106) 106
area under curve (103) 103
molecular structure (102) 102
sulfones - administration & dosage (101) 101
double-blind method (100) 100
chemistry, organic (98) 98
impotence (97) 97
cardiac & cardiovascular systems (96) 96
hypertension, pulmonary - drug therapy (96) 96
medicine (96) 96
oxidases (96) 96
phosphodiesterase inhibitors - pharmacokinetics (95) 95
young adult (95) 95
cells (94) 94
inhibitors (94) 94
sulfones - pharmacokinetics (93) 93
antineoplastic agents - therapeutic use (92) 92
apoptosis (92) 92
adolescent (90) 90
nitric-oxide (90) 90
research article (90) 90
disease models, animal (89) 89
chromatography, high pressure liquid (87) 87
nucleosides (87) 87
chemistry, analytical (84) 84
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2447) 2447
German (18) 18
Japanese (6) 6
Spanish (5) 5
Chinese (4) 4
French (4) 4
Polish (3) 3
Dutch (2) 2
Russian (2) 2
Danish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 12/2010, Volume 49, Issue 12, pp. 829 - 840
Linagliptin (BI 1356) is a highly specific inhibitor of dipeptidyl peptidase (DPP)-4, which is currently in phase III clinical development for the treatment of... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Research-and-development | Population-pharmacokinetics | Antihyperglycaemics, pharmacokinetics | Linagliptin, pharmacokinetics | Bioavailability | Dipeptidyl-peptidase-inhibitors, pharmacodynamics | Pharmacokinetic-pharmacodynamic-relationships | Linagliptin, pharmacodynamics | Pharmacokinetic-modelling | Dipeptidyl-peptidase-inhibitors, pharmacokinetics | Antihyperglycaemics, pharmacodynamics | TARGET | MEDIATED DRUG DISPOSITION | TYPE-2 DIABETIC-PATIENTS | PLASMA | GLUCAGON-LIKE PEPTIDE-1 | TOLERABILITY | VOLUNTEERS | PHARMACOLOGY & PHARMACY | PROTEIN BINDING | BENAZEPRILAT | POLYPEPTIDE | Single-Blind Method | Dipeptidyl Peptidase 4 - metabolism | Tablets | Area Under Curve | Humans | Middle Aged | Half-Life | Quinazolines - pharmacokinetics | Biological Availability | Male | Purines - administration & dosage | Dose-Response Relationship, Drug | Tissue Distribution | Young Adult | Quinazolines - metabolism | Adult | Dipeptidyl-Peptidase IV Inhibitors - metabolism | Quinazolines - administration & dosage | Linagliptin | Purines - metabolism | Purines - pharmacokinetics | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Cross-Over Studies | Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics | Models, Biological | Adolescent | Protein Binding | Infusions, Intravenous | Type 2 diabetes | Complications and side effects | Hypoglycemic agents | Dosage and administration | Research | Pharmacokinetics | Drug therapy
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 8/2013, Volume 208, Issue 3, pp. 512 - 519
Journal Article